During the past decade, Providence Cancer Center at Providence Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 20 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Providence Cancer Center at Providence Hospital" #1 sponsor was "SWOG Cancer Research Network" with 15 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "Radiation Therapy Oncology Group" with 4 trials sponsored, "NSABP Foundation Inc" with 2 trials sponsored and "Sanofi" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Cancer Center at Providence Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 30 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Providence Cancer Center at Providence Hospital" are "Breast Cancer" (11 trials), "Colorectal Cancer" (7 trials), "Lung Cancer" (6 trials), "Metastatic Cancer" (6 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "Providence Cancer Center at Providence Hospital" in a lesser frequency.

Most popular intervention types in "Providence Cancer Center at Providence Hospital" are "Drug" (23 trials), "Other" (13 trials), "Radiation" (7 trials), "Biological" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (6 trials), "cyclophosphamide" (4 trials), "oxaliplatin" (4 trials), "biologic sample preservation procedure" (3 trials) and "doxorubicin hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Providence Cancer Center at Providence Hospital" are 22 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Providence Cancer Center at Providence Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Providence Cancer Center at Providence Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Providence Cancer Center at Providence Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".